NYSE International 100
10.669,18
PKT
-206,64
PKT
-1,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.03.20 | Novartis buy | Oddo BHF | |
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 31.03.20 | GSK Neutral | Oddo BHF | |
| 31.03.20 | Sanofi buy | Oddo BHF | |
| 31.03.20 | Philips Neutral | Credit Suisse Group | |
| 31.03.20 | Mercedes-Benz Group (ex Daimler) Sell | Goldman Sachs Group Inc. | |
| 31.03.20 | Siemens buy | Goldman Sachs Group Inc. | |
| 31.03.20 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.03.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 31.03.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 31.03.20 | ING Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.03.20 | BBVA buy | Goldman Sachs Group Inc. | |
| 31.03.20 | Santander Conviction Buy | Goldman Sachs Group Inc. | |
| 31.03.20 | UBS buy | Goldman Sachs Group Inc. | |
| 31.03.20 | UBS buy | Goldman Sachs Group Inc. | |
| 31.03.20 | Deutsche Bank Neutral | Goldman Sachs Group Inc. | |
| 30.03.20 | UBS Verkaufen | DZ BANK | |
| 30.03.20 | AXA overweight | Morgan Stanley | |
| 30.03.20 | Prudential overweight | Morgan Stanley | |
| 30.03.20 | Allianz Equal-Weight | Morgan Stanley | |
| 30.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.03.20 | GSK buy | UBS AG | |
| 30.03.20 | ING Group buy | UBS AG | |
| 30.03.20 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 30.03.20 | ING Group buy | Kepler Cheuvreux | |
| 30.03.20 | Siemens buy | Kepler Cheuvreux | |
| 30.03.20 | Vodafone Group overweight | Barclays Capital | |
| 30.03.20 | Diageo buy | Goldman Sachs Group Inc. | |
| 30.03.20 | BT Group Underweight | Barclays Capital | |
| 30.03.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 30.03.20 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 30.03.20 | Orange buy | Goldman Sachs Group Inc. | |
| 30.03.20 | Telefonica overweight | Barclays Capital | |
| 30.03.20 | Orange Equal weight | Barclays Capital | |
| 30.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.03.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.03.20 | Deutsche Telekom Underweight | Barclays Capital | |
| 30.03.20 | BT Group Neutral | UBS AG | |
| 30.03.20 | Philips Outperform | Bernstein Research |
